Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

137 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment.
Pouessel D, Neuzillet Y, Mertens LS, van der Heijden MS, de Jong J, Sanders J, Peters D, Leroy K, Manceau A, Maille P, Soyeux P, Moktefi A, Semprez F, Vordos D, de la Taille A, Hurst CD, Tomlinson DC, Harnden P, Bostrom PJ, Mirtti T, Horenblas S, Loriot Y, Houédé N, Chevreau C, Beuzeboc P, Shariat SF, Sagalowsky AI, Ashfaq R, Burger M, Jewett MA, Zlotta AR, Broeks A, Bapat B, Knowles MA, Lotan Y, van der Kwast TH, Culine S, Allory Y, van Rhijn BW. Pouessel D, et al. Among authors: houede n. Ann Oncol. 2016 Jul;27(7):1311-6. doi: 10.1093/annonc/mdw170. Epub 2016 Apr 18. Ann Oncol. 2016. PMID: 27091807 Free PMC article.
[Chemoradiotherapy for muscle-invasive cancer: methods, surveillance and results. An update from the cancer committee of the French National Association of Urology].
Quintens H, Roupret M, Larré S, Neuzillet Y, Pignot G, Compérat E, Wallerand H, Houédé N, Roy C, Soulié M, Pfister C; Membres du CC-AFU. Quintens H, et al. Among authors: houede n. Prog Urol. 2012 Jan;22(1):13-6. doi: 10.1016/j.purol.2011.09.016. Epub 2011 Nov 9. Prog Urol. 2012. PMID: 22196000 French.
[Chemotherapy in perioperative setting for infiltrative bladder cancer].
Houédé N, Beuzeboc P, Culine S, Soulié M, Pfister C; Groupe vessie du Comité de cancérologie de l’Association française d’urologie. Houédé N, et al. Prog Urol. 2012 Mar;22(3):139-45. doi: 10.1016/j.purol.2011.09.010. Epub 2011 Oct 28. Prog Urol. 2012. PMID: 22364623 Review. French.
[Benefit of bladder and upper urinary tract urothelial tumors lymph node dissection: review from the Bladder Cancer Committee of the French National Association of Urology ("CC-AFU Vessie")].
Larré S, Quintens H, Houéde N, Compérat E, Roy C, Pignot G, Rouprêt M, Neuzillet Y, Wallerand H, Soulié M, Pfister C. Larré S, et al. Among authors: houede n. Prog Urol. 2012 Jun;22(7):380-7. doi: 10.1016/j.purol.2012.02.002. Epub 2012 Mar 29. Prog Urol. 2012. PMID: 22657257 Review. French.
[Intradiverticular bladder tumours: review of the Cancer Committee of the French Association of Urology].
Neuzillet Y, Comperat E, Rouprêt M, Larre S, Roy C, Quintens H, Houede N, Pignot G, Wallerand H, Soulie M, Pfister C; Membres du Comité de cancérologie de l’Association française d’urologie. Neuzillet Y, et al. Among authors: houede n. Prog Urol. 2012 Jul;22(9):495-502. doi: 10.1016/j.purol.2012.03.008. Epub 2012 Apr 28. Prog Urol. 2012. PMID: 22732640 Review. French.
[Surgical treatment of metastatic urothelial carcinoma of the bladder: Review of the Cancer Committee of the French Association of Urology].
Neuzillet Y, Larré S, Comperat E, Rouprêt M, Pignot G, Houede N, Quintens H, Wallerand H, Roy C, Soulie M, Pfister C; les membres du Comité de cancérologie de l’Association française d’urologie. Neuzillet Y, et al. Among authors: houede n. Prog Urol. 2013 Oct;23(12):951-7. doi: 10.1016/j.purol.2013.03.004. Epub 2013 Apr 17. Prog Urol. 2013. PMID: 24090779 Review. French.
[CCAFU Recommendations 2013: Bladder carcinoma].
Pfister C, Roupret M, Neuzillet Y, Larré S, Pignot G, Quintens H, Houedé N, Compérat E, Colin P, Roy C, Davin JL, Guy L, Irani J, Lebret T, Coloby P, Soulié M; Les membres du CCAFU. Pfister C, et al. Among authors: houede n. Prog Urol. 2013 Nov;23 Suppl 2:S105-25. doi: 10.1016/S1166-7087(13)70049-6. Prog Urol. 2013. PMID: 24485286 French.
Combining gemcitabine, cisplatin, and ifosfamide (GIP) is active in patients with relapsed metastatic germ-cell tumors (GCT): a prospective multicenter GETUG phase II trial.
Fizazi K, Gravis G, Flechon A, Geoffrois L, Chevreau C, Laguerre B, Delva R, Eymard JC, Rolland F, Houede N, Laplanche A, Burcoveanu D, Culine S. Fizazi K, et al. Among authors: houede n. Ann Oncol. 2014 May;25(5):987-91. doi: 10.1093/annonc/mdu099. Epub 2014 Mar 4. Ann Oncol. 2014. PMID: 24595454 Free article. Clinical Trial.
Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project†.
Kramar A, Negrier S, Sylvester R, Joniau S, Mulders P, Powles T, Bex A, Bonnetain F, Bossi A, Bracarda S, Bukowski R, Catto J, Choueiri TK, Crabb S, Eisen T, El Demery M, Fitzpatrick J, Flamand V, Goebell PJ, Gravis G, Houédé N, Jacqmin D, Kaplan R, Malavaud B, Massard C, Melichar B, Mourey L, Nathan P, Pasquier D, Porta C, Pouessel D, Quinn D, Ravaud A, Rolland F, Schmidinger M, Tombal B, Tosi D, Vauleon E, Volpe A, Wolter P, Escudier B, Filleron T; DATECAN Renal Cancer group. Kramar A, et al. Among authors: houede n. Ann Oncol. 2015 Dec;26(12):2392-8. doi: 10.1093/annonc/mdv380. Epub 2015 Sep 14. Ann Oncol. 2015. PMID: 26371288 Free article. Review.
Le cancer de vessie chez le sujet jeune, une étude de population française.
Compérat E, Larré S, Neuzillet Y, Vordos D, Soulié M, Azzouzi A, Pignot G, Durand X, Quintens H, Houede N, Jeglischi S, El Bakri A, Bigot P, Lebdai S, Rouprêt M, Pfister C. Compérat E, et al. Among authors: houede n. Prog Urol. 2014 Nov;24(13):846. doi: 10.1016/j.purol.2014.08.140. Epub 2014 Oct 30. Prog Urol. 2014. PMID: 26461667 French. No abstract available.
137 results